Research On Strategic Transformation Of AZ(China)enterprise Under The Background Of New Medical Reform

With the comprehensive economic strength of the upgrade,China’s national image glance,obvious to people development of science education culture and health field,in the field of health,especially in the field of medical and health undertakings,after the 2009 implementation of the new medical reform measures,and achieved remarkable achievement in innovation over the past ten years of reform,continue to meet the public health needs.AZ is a company with 60 thousand employees in the world’s major multinational pharmaceutical companies,the three major drugs supply base in China established has become the Asian market front,as competition intensifies,AZ(China)enterprises are facing slowdown,declining market share,the original development strategy has been unable to meet the future development of the enterprise the demand.Therefore,based on the background of new healthcare reform,analyzing the internal and external thixotropic factors of AZ(China)enterprises,it is of great significance to develop strategies of transformation scientifically and rationally to improve their market competitiveness.This article mainly takes the strategic transformation of the enterprise as the clue,focuses on the case study method,studies the strategic transformation of AZ(China)according to the actual situation and real time data of the enterprise,and combines the specific content of the new medical reform policy and the internal and external environment of the development of the AZ(China),summarizes the existing problems of the enterprise strategy at the present stage,and carries out the section in accordance with its strategic objectives.To identify the orientation and path of strategic transformation under the background of new healthcare reform,From the four aspects of the organization,capital,scientific research and human resources of AZ(China),the paper puts forward the safeguard measures of strategic implementation,innovatively puts forward the industrial chain with the integration of drug R & D,manufacturing,sales and supply,and formulating the differential service system and taking up the emerging markets,and forming a strategic transformation plan of four in one.Under the background of the new medical reform,the aim is to cater to the development opportunity of the pharmaceutical market,to enhance the comprehensive competitiveness of the AZ(China),and to provide effective reference for other enterprises in the same industry.